Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: R23ZRN6GWR

Pharmacology

Action Mechanism of Action Reference
INHIBITOR 80S Ribosome inhibitor Other Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Lymphoma, Non-Hodgkin 2 D008228 ClinicalTrials
Leukemia, Lymphoid 1 D007945 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297789
FDA SRS R23ZRN6GWR